Literature DB >> 9371612

The murine coronavirus mouse hepatitis virus strain A59 from persistently infected murine cells exhibits an extended host range.

J H Schickli1, B D Zelus, D E Wentworth, S G Sawicki, K V Holmes.   

Abstract

In murine 17 Cl 1 cells persistently infected with murine coronavirus mouse hepatitis virus strain A59 (MHV-A59), expression of the virus receptor glycoprotein MHVR was markedly reduced (S. G. Sawicki, J. H. Lu, and K. V. Holmes, J. Virol. 69:5535-5543, 1995). Virus isolated from passage 600 of the persistently infected cells made smaller plaques on 17 Cl 1 cells than did MHV-A59. Unlike the parental MHV-A59, this variant virus also infected the BHK-21 (BHK) line of hamster cells. Virus plaque purified on BHK cells (MHV/BHK) grew more slowly in murine cells than did MHV-A59, and the rate of viral RNA synthesis was lower and the development of the viral nucleocapsid (N) protein was slower than those of MHV-A59. MHV/BHK was 100-fold more resistant to neutralization with the purified soluble recombinant MHV receptor glycoprotein (sMHVR) than was MHV-A59. Pretreatment of 17 Cl 1 cells with anti-MHVR monoclonal antibody CC1 protected the cells from infection with MHV-A59 but only partially protected them from infection with MHV/BHK. Thus, although MHV/BHK could still utilize MHVR as a receptor, its interactions with the receptor were significantly different from those of MHV-A59. To determine whether a hemagglutinin esterase (HE) glycoprotein that could bind the virions to 9-O-acetylated neuraminic acid moieties on the cell surface was expressed by MHV/BHK, an in situ esterase assay was used. No expression of HE activity was detected in 17 Cl 1 cells infected with MHV/BHK, suggesting that this virus, like MHV-A59, bound to cell membranes via its S glycoprotein. MHV/BHK was able to infect cell lines from many mammalian species, including murine (17 Cl 1), hamster (BHK), feline (Fcwf), bovine (MDBK), rat (RIE), monkey (Vero), and human (L132 and HeLa) cell lines. MHV/BHK could not infect dog kidney (MDCK I) or swine testis (ST) cell lines. Thus, in persistently infected murine cell lines that express very low levels of virus receptor MHVR and which also have and may express alternative virus receptors of lesser efficiency, there is a strong selective advantage for virus with altered interactions with receptor (D. S. Chen, M. Asanaka, F. S. Chen, J. E. Shively, and M. M. C. Lai, J. Virol. 71:1688-1691, 1997; D. S. Chen, M. Asanaka, K. Yokomori, F.-I. Wang, S. B. Hwang, H.-P. Li, and M. M. C. Lai, Proc. Natl. Acad. Sci. USA 92:12095-12099, 1995; P. Nedellec, G. S. Dveksler, E. Daniels, C. Turbide, B. Chow, A. A. Basile, K. V. Holmes, and N. Beauchemin, J. Virol. 68:4525-4537, 1994). Possibly, in coronavirus-infected animals, replication of the virus in tissues that express low levels of receptor might also select viruses with altered receptor recognition and extended host range.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371612      PMCID: PMC230256     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding.

Authors:  F Taguchi
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 2.  The biology and pathogenesis of coronaviruses.

Authors:  H Wege; S Siddell; V ter Meulen
Journal:  Curr Top Microbiol Immunol       Date:  1982       Impact factor: 4.291

3.  Evolution of a coronavirus during persistent infection in vitro.

Authors:  K V Holmes; J N Behnke
Journal:  Adv Exp Med Biol       Date:  1981       Impact factor: 2.622

4.  Coronavirus minus-strand RNA synthesis and effect of cycloheximide on coronavirus RNA synthesis.

Authors:  S G Sawicki; D L Sawicki
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

5.  Entry of coronavirus into primate CNS following peripheral infection.

Authors:  G F Cabirac; K F Soike; J Y Zhang; K Hoel; C Butunoi; G Y Cai; S Johnson; R S Murray
Journal:  Microb Pathog       Date:  1994-05       Impact factor: 3.738

6.  Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion.

Authors:  M F Frana; J N Behnke; L S Sturman; K V Holmes
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

7.  Persistent infection of cultured cells with mouse hepatitis virus (MHV) results from the epigenetic expression of the MHV receptor.

Authors:  S G Sawicki; J H Lu; K V Holmes
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

8.  Characterization and transcriptional activity of the mouse biliary glycoprotein 1 gene, a carcinoembryonic antigen-related gene.

Authors:  P Nédellec; C Turbide; N Beauchemin
Journal:  Eur J Biochem       Date:  1995-07-01

9.  In vivo and in vitro models of demyelinating disease. XI. Tropism and differentiation regulate the infectious process of coronaviruses in primary explants of the rat CNS.

Authors:  S Beushausen; S Dales
Journal:  Virology       Date:  1985-02       Impact factor: 3.616

10.  AN ELECTRON MICROSCOPE STUDY OF THE DEVELOPMENT OF A MOUSE HEPATITIS VIRUS IN TISSUE CULTURE CELLS.

Authors:  J F DAVID-FERREIRA; R A MANAKER
Journal:  J Cell Biol       Date:  1965-01       Impact factor: 10.539

View more
  38 in total

1.  Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37 degrees C either by soluble murine CEACAM1 receptors or by pH 8.

Authors:  Bruce D Zelus; Jeanne H Schickli; Dianna M Blau; Susan R Weiss; Kathryn V Holmes
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 2.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

3.  Prevalence and genetic diversity of coronaviruses in bats from China.

Authors:  X C Tang; J X Zhang; S Y Zhang; P Wang; X H Fan; L F Li; G Li; B Q Dong; W Liu; C L Cheung; K M Xu; W J Song; D Vijaykrishna; L L M Poon; J S M Peiris; G J D Smith; H Chen; Y Guan
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  Cooperative involvement of the S1 and S2 subunits of the murine coronavirus spike protein in receptor binding and extended host range.

Authors:  Cornelis A M de Haan; Eddie Te Lintelo; Zhen Li; Matthijs Raaben; Tom Wurdinger; Berend Jan Bosch; Peter J M Rottier
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

5.  Cleavage of group 1 coronavirus spike proteins: how furin cleavage is traded off against heparan sulfate binding upon cell culture adaptation.

Authors:  C A M de Haan; B J Haijema; P Schellen; P Wichgers Schreur; E te Lintelo; H Vennema; P J M Rottier
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

6.  Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier.

Authors:  L Kuo; G J Godeke; M J Raamsman; P S Masters; P J Rottier
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

7.  Receptor-independent infection of murine coronavirus: analysis by spinoculation.

Authors:  Rie Watanabe; Shutoku Matsuyama; Fumihiro Taguchi
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

8.  Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor.

Authors:  Cornelis A M de Haan; Zhen Li; Eddie te Lintelo; Berend Jan Bosch; Bert Jan Haijema; Peter J M Rottier
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

9.  Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR.

Authors:  Laura Gillim-Ross; Jill Taylor; David R Scholl; Jared Ridenour; Paul S Masters; David E Wentworth
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

10.  Persistent infection promotes cross-species transmissibility of mouse hepatitis virus.

Authors:  R S Baric; E Sullivan; L Hensley; B Yount; W Chen
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.